Dr. Janice Rafferty, MD

Dr. Rafferty practices at Christ Hospital Medical Specialists LLC in Cincinnati, Ohio.

Dr. Rafferty's NPI, 1871561464, was assigned on March 9, 2006. Dr. Rafferty graduated from Ohio State College of Medicine in 1988. Dr. Rafferty holds Ohio license 35-059681.

Dr. Rafferty's primary practice is Christ Hospital Medical Specialists LLC, at 2123 Auburn Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 351-9900.

Dr. Rafferty's primary practice is Christ Hospital Medical Specialists LLC in Cincinnati, Ohio. Dr. Rafferty is also affiliated with The Christ Hospital. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Rafferty to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rafferty practices, 3 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Rafferty's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Rafferty is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dr. Rafferty is licensed in Ohio.

Dmand AI lists colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Rafferty treats.

CMS data shows 220 Medicare services from Dr. Rafferty across 8 procedure codes in 2024, for 162 Medicare patients. Medicare paid $18,518 for them.

CMS counts 162 Medicare patients who saw Dr. Rafferty in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rafferty's median patient age at 63, with 62% women.

In 2024, Dr. Rafferty wrote 85 Medicare Part D claims for 38 patients. 94% of them were for generic drugs. CMS names the drug for 46 of them, across 3 drugs with 11 or more claims each, at $1,037 in total drug cost. In 2023, CMS named 54 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Rafferty for performance year 2024, reported as part of a group. Dr. Rafferty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 39 procedures of colonoscopy by Dr. Rafferty, more than 58% of the clinicians it reports for that procedure.

Dmand AI links 46 papers to Dr. Rafferty, published from 2013 to 2023. 2014 was the busiest year, with 5. The most frequent topics are Colectomy, Fecal Incontinence and Anal Canal. Dr. Rafferty has published most often in Dis Colon Rectum. Dr. Rafferty's most frequent co-authors are Ian M. Paquette, MD, Scott Russell Steele, MD and Shimul A. Shah, MD.

Dmand AI links Dr. Rafferty to 1 clinical trial. Conditions studied include Surgical Wound Infection and Wound Infection.

CMS Open Payments shows 256 general payments to Dr. Rafferty from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Stryker Corporation paid the most, $197,437.

Dmand AI lists 5 awards for Dr. Rafferty, most recently America's Top Doctors in 2014. Dr. Rafferty serves on ASCRS Clinical Practice Guideline Committee.

Dr. Rafferty graduated from Ohio State College of Medicine in 1988. Dr. Rafferty is a member of ACS and ASCRS.

Dr. Rafferty is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.